FOI_7724

Internal Reference Number: FOI_7724

Date Request Received: 02/02/2024 00:00:00

Date Request Replied To: 21/02/2024 00:00:00

This response was sent via: By Email

Request Summary: request on biologic medicines in gastroenterology

Request Category: Companies


Question Number 1: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Vedolizumab

Answer To Question 1: • Adalimumab - Humira - 9 • Adalimumab Biosimilar - 40 • Etrasimod - N/A not used at SFT • Filgotinib - 14 • Golimumab - <5 • Infliximab - Remicade - 19 • Infliximab Biosimilar - 188 • Mirikizumab - N/A not used at SFT • Ozanimod - N/A not used at SFT • Risankizumab - 0 • Tofacitinib - <5 • Upadacitinib - 9 • Ustekinumab - 53 • Vedolizumab - 89

Question Number 2: If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Vedolizumab

Answer To Question 2: • Adalimumab - Humira - 9 • Adalimumab Biosimilar - 8 • Etrasimod - 0 • Filgotinib - 9 • Golimumab - <5 • Infliximab - Remicade - 6 • Infliximab Biosimilar - 76 • Mirikizumab - 0 • Ozanimod - 0 • Risankizumab - 0 • Tofacitinib - <5 • Upadacitinib - <5 • Ustekinumab - 10 • Vedolizumab - 45

To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.